Tracking breast cancer cells on the move

June 14, 2012

Breast cancer cells frequently move from their primary site and invade bone, decreasing a patient's chance of survival. This process of metastasis is complex, and factors both within the breast cancer cells and within the new bone environment play a role. In next week's Journal of Biological Chemistry "Paper of the Week," Roger Gomis and colleagues at the Institute for Research in Biomedicine in Spain investigated how breast cancer cells migrate to bone.

In particular, they examined the role of NOG, a gene important to proper bone development. Previously, NOG was associated with in prostate cancer, but its specific role in breast cancer to bone metastasis remained unknown.

Gomis and colleagues showed that once are on the move NOG enables them to specifically invade the bone and establish a tumor. It does this in two ways. First, NOG escalates bone degeneration by increasing the number of mature osteoclasts (bone cells that break down bone), essentially creating a spot in the bone for the metastatic breast cancer cells to take up residence. Second, NOG keeps the cells in a stem-cell-like state, which enables them to propagate and form a new tumor in the bone environment.

Gomis explains that the reason NOG expression leads to an increased potential for breast cancer to bone metastasis is because it not only affects features inherent to aggressive cancer cells (such as the ability to establish a new tumor) but also influences properties of the bone environment (such as osteoclast degeneration of bone).

Explore further: Bone drug could help prevent the spread of breast cancer

More information: "Identification of NOG as a specific breast cancer bone metastasis-supporting gene" by Maria Tarragona, Milica Pavlovic, Anna Arnal-Estapé, Jelena Urosevic, Mònica Morales, Marc Guiu, Evarist Planet, Eva González-Suárez, Roger R. Gomis, www.jbc.org/content/early/2012/04/30/jbc.M112.355834.full.pdf+html

Related Stories

Targeting MMPs to halt advanced metastatic breast cancer

July 16, 2009

An upcoming G&D paper reveals how two specific matrix metalloproteinase (MMP) proteins contribute to bone metastasis in advanced breast cancer - lending important new insight into the design of clinically useful small molecule ...

Experimental agent reduces breast cancer metastasis to bone

November 3, 2009

Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer. In a study in mice, the team of researchers ...

Recommended for you

Brazilian wasp venom kills cancer cells by opening them up

September 1, 2015

The social wasp Polybia paulista protects itself against predators by producing venom known to contain a powerful cancer-fighting ingredient. A Biophysical Journal study published September 1 reveals exactly how the venom's ...

Naturally-occurring protein enables slower-melting ice cream

August 31, 2015

(Phys.org)—Scientists have developed a slower-melting ice cream—consider the advantages the next time a hot summer day turns your child's cone with its dream-like mound of orange, vanilla and lemon swirls with chocolate ...

Antibody-making bacteria promise drug development

August 31, 2015

Monoclonal antibodies, proteins that bind to and destroy foreign invaders in our bodies, routinely are used as therapeutic agents to fight a wide range of maladies including breast cancer, leukemia, asthma, arthritis, psoriasis, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.